If you’re looking for alternatives to surgery for knee pain, you may have come across two increasingly discussed options:
peptide therapy and platelet-rich plasma, or PRP.
Both are often placed under the broad umbrella of regenerative medicine. But they are not the same treatment, they do not work the same way, and—perhaps most importantly—the amount of human research supporting them is very different.
For Dr. Emeka Ofobike, orthopedic surgeon and founder of Vessel Longevity, the conversation starts with something more fundamental:
What is actually causing your knee pain?
Because treating osteoarthritis is different from treating a tendon injury, muscle weakness, inflammation, a meniscus problem, or advanced joint degeneration.
What Is PRP?
PRP stands for platelet-rich plasma.
It begins with your own blood. A blood sample is drawn and processed to concentrate platelets and other components of plasma. That concentrated preparation is then injected into the area being treated.
Platelets are best known for helping blood clot, but they also contain signaling molecules and growth factors involved in the body’s healing response.
In knee osteoarthritis, PRP is generally used with the goal of reducing symptoms and improving function rather than replacing lost cartilage.
That’s an important distinction.
PRP should not be described as a treatment that can reliably “regrow” an arthritic knee.
The American Academy of Orthopaedic Surgeons states that PRP may reduce pain and improve function in patients with symptomatic knee osteoarthritis, although it gives the treatment a limited-strength recommendation because studies and PRP formulations vary considerably. AAOS
Read the AAOS Knee Osteoarthritis Clinical Practice Guideline
What Does the Research Say About PRP for Knee Pain?
Compared with emerging peptide therapies, PRP has considerably more human clinical research behind it.
But the findings are not perfectly consistent.
A 2025 systematic review and meta-analysis of 11 randomized trials involving 1,616 patients found that PRP produced improvements in pain at three and six months compared with saline injections, although benefits were not demonstrated at 12 months. Researchers described the overall effect as modest and noted significant variation among studies. PubMed
Read the 2025 PRP systematic review on PubMed
Other reviews have reported improvements in pain and function, particularly in patients with mild-to-moderate knee osteoarthritis, while continuing to emphasize differences in PRP preparation, patient selection and study design. PubMed
In other words:
PRP has legitimate clinical research behind it—but it is not a guaranteed solution for every painful knee.
What Are Peptides for Knee Pain?
Peptides are short chains of amino acids that can act as signaling molecules in the body.
In regenerative and sports-medicine conversations, patients frequently ask about peptides such as BPC-157 and TB-500 because they are promoted online for tissue healing, inflammation and recovery.
This is where the evidence becomes very different from PRP.
BPC-157, for example, has generated interesting laboratory and animal research involving tendon, ligament, muscle and other tissues.
Human evidence, however, remains extremely limited.
A systematic review of BPC-157 in orthopedic sports medicine identified 35 preclinical studies and only one human clinical study. The authors also noted the lack of FDA approval and the absence of adequate clinical safety data. PubMed
Read the BPC-157 orthopedic systematic review on PubMed
The FDA has also identified BPC-157 as a substance for which there is insufficient safety information regarding proposed human use and has raised concerns about potential immunogenicity and peptide-related impurities in compounded products. U.S. Food and Drug Administration
So while peptide science is interesting, promising biological mechanisms should not be confused with proven clinical outcomes.
Peptides vs. PRP: Is One Better?
Not necessarily—and that may be the wrong question.
PRP and peptides are fundamentally different.
PRP uses components concentrated from your own blood and is typically injected locally into the affected area.
Peptide therapies use specific signaling molecules or peptide compounds intended to influence biological processes in the body.
For knee osteoarthritis specifically, PRP currently has a substantially larger body of human clinical evidence.
For emerging peptides such as BPC-157, most of the musculoskeletal evidence is still preclinical.
But even with PRP, treatment should not begin with:
“Which injection should I get?”
It should begin with:
“Why does my knee hurt?”
The Knee Is More Than Cartilage
This is where an orthopedic evaluation becomes particularly important.
Dr. Emeka looks at the entire functional picture:
- How advanced is the arthritis?
- What does imaging show?
- Where is the pain actually coming from?
- How much muscle supports the joint?
- Is mobility decreasing?
- Has the patient’s activity level changed?
- Is excess body weight adding mechanical stress?
- Are there alignment or structural problems?
- What activities does the patient want to return to?
A patient with early osteoarthritis who still has good joint space and wants to remain active may have a very different treatment plan from someone with advanced bone-on-bone disease, significant deformity and major limitations in everyday life.
Where Regenerative Medicine Fits at Vessel
At Vessel Longevity, regenerative medicine can be considered as part of a broader orthopedic and longevity strategy, when appropriate.
The goal isn’t to select a treatment because it is new or labeled “regenerative.”
It’s to understand the joint, the patient’s body composition, muscle mass, mobility, metabolic health and long-term goals—and then determine which tools may reasonably support those goals.
That might involve strengthening and physical therapy, improving body composition, addressing inflammation and metabolic health, regenerative medicine, or conventional orthopedic treatment.
And sometimes, surgery really is the appropriate treatment.
The Bigger Goal: Preserve Function
For Dr. Emeka, the ultimate objective isn’t simply to make a knee hurt less for a few months.
It’s to help patients maintain strength, mobility and the ability to continue doing the things that matter to them.
PRP currently has more human evidence supporting its use for certain patients with knee osteoarthritis than emerging peptides such as BPC-157.
But neither should be viewed as a universal solution—or a guaranteed way to regenerate severely damaged cartilage.
The better approach is precision medicine:
Understand the knee. Understand the patient. Define the goal. Then choose the treatment.
Interested in Regenerative Options for Knee Pain?
If knee pain is limiting your activity—or you’re trying to understand your options before considering surgery—Vessel Longevity can evaluate your joint health, mobility, muscle mass and overall health to determine which orthopedic and regenerative strategies may be appropriate.
Schedule a consultation with Dr. Emeka and the Vessel Longevity team to discuss your options.